NCT03035032 2024-11-26A Study of ELIGARD® in Hormone-dependent Prostate Cancer PatientsAstellas Pharma IncPhase 4 Completed107 enrolled 25 charts
NCT01136226 2018-10-24EligardChesapeake Urology Research AssociatesPhase 4 Completed42 enrolled 5 charts